Consolidated statement of changes in equity
January 1 – December 31
|
|
|
|
|
Attributable to shareholders of medmix Ltd |
|
|
|
|
||||||||||
|
millions of CHF |
|
|
Share capital |
|
Retained earnings |
|
Treasury shares |
|
Cash flow hedge reserve |
|
Currency translation adjustment |
|
Total |
|
Non-controlling interests |
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2023 |
|
|
|
0.4 |
|
540.3 |
|
–12.5 |
|
0.7 |
|
–24.1 |
|
504.8 |
|
– |
|
504.8 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
0.3 |
|
|
|
|
|
|
|
0.3 |
|
0.4 |
|
0.7 |
|
– Cash flow hedges, net of tax |
|
|
– |
|
– |
|
– |
|
–1.6 |
|
– |
|
–1.6 |
|
– |
|
–1.6 |
|
|
– Remeasurements of defined benefit plans, net of tax |
|
|
– |
|
19.5 |
|
– |
|
– |
|
– |
|
19.5 |
|
– |
|
19.5 |
|
|
– Currency translation differences |
|
|
|
– |
|
– |
– |
– |
– |
– |
– |
–24.6 |
|
–24.6 |
|
–0.4 |
|
–25.0 |
|
Other comprehensive income |
|
|
|
– |
|
19.5 |
|
– |
|
–1.6 |
|
–24.6 |
|
–6.7 |
|
–0.4 |
|
–7.1 |
|
Total comprehensive income for the period |
|
|
|
– |
|
19.8 |
|
– |
|
–1.6 |
|
–24.6 |
|
–6.4 |
|
–0.0 |
|
–6.4 |
|
Sale of investments in subsidiaries |
|
|
|
– |
|
–2.0 |
|
– |
|
– |
|
– |
|
–2.0 |
|
– |
|
–2.0 |
|
Put option liability |
|
|
|
– |
|
–9.8 |
|
– |
|
– |
|
– |
|
–9.8 |
|
– |
|
–9.8 |
|
Contribution to the Sulzer group |
|
|
– |
|
–0.3 |
|
– |
|
– |
|
– |
|
–0.3 |
|
– |
|
–0.3 |
|
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquisition of subsidiary with non-controlling interests |
|
|
– |
|
– |
|
– |
|
– |
|
– |
|
– |
|
9.0 |
|
9.0 |
|
|
Allocation of treasury shares to share plan participants |
|
|
– |
|
–0.4 |
|
0.4 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
|
Purchase of treasury shares |
|
|
– |
|
– |
|
–3.1 |
|
– |
|
– |
|
–3.1 |
|
– |
|
–3.1 |
|
|
Share-based payments |
|
|
– |
|
2.5 |
|
– |
|
– |
|
– |
|
2.5 |
|
– |
|
2.5 |
|
|
Dividends |
|
|
– |
|
–20.5 |
|
– |
|
– |
|
– |
|
–20.5 |
|
– |
|
–20.5 |
|
|
Equity as of December 31, 2023 |
|
|
0.4 |
|
529.8 |
|
–15.2 |
|
–0.9 |
|
–48.7 |
|
465.4 |
|
9.0 |
|
474.3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity as of January 1, 2024 |
|
|
|
0.4 |
|
529.8 |
|
–15.2 |
|
–0.9 |
|
–48.7 |
|
465.4 |
|
9.0 |
|
474.3 |
|
Comprehensive income for the period: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
–7.4 |
|
|
|
|
|
|
|
–7.4 |
|
1.0 |
|
–6.4 |
|
– Cash flow hedges, net of tax |
|
|
– |
|
– |
|
– |
|
–5.0 |
|
– |
|
–5.0 |
|
– |
|
–5.0 |
|
|
– Remeasurements of defined benefit plans, net of tax |
|
|
– |
|
–1.3 |
|
– |
|
– |
|
– |
|
–1.3 |
|
– |
|
–1.3 |
|
|
– Currency translation differences |
|
|
|
– |
|
– |
– |
– |
– |
– |
|
6.3 |
|
6.3 |
|
0.4 |
|
6.7 |
|
Other comprehensive income |
|
|
|
– |
|
–1.3 |
|
– |
|
–5.0 |
|
6.3 |
|
–0.0 |
|
0.4 |
|
0.3 |
|
Total comprehensive income for the period |
|
|
|
– |
|
–8.7 |
|
– |
|
–5.0 |
|
6.3 |
|
–7.4 |
|
1.4 |
|
–6.0 |
|
Subsequent measurement of put option liabilities |
|
|
– |
|
–5.0 |
|
– |
|
– |
|
– |
|
–5.0 |
|
– |
|
–5.0 |
|
|
Contribution to the Sulzer group |
|
|
– |
|
–0.1 |
|
– |
|
– |
|
– |
|
–0.1 |
|
– |
|
–0.1 |
|
|
Transactions with owners of the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of treasury shares to share plan participants |
|
|
– |
|
–1.1 |
|
1.1 |
|
– |
|
– |
|
– |
|
– |
|
– |
|
|
Purchase of treasury shares |
|
|
– |
|
– |
|
–0.5 |
|
– |
|
– |
|
–0.5 |
|
– |
|
–0.5 |
|
|
Share-based payments |
|
|
– |
|
4.4 |
|
– |
|
– |
|
– |
|
4.4 |
|
– |
|
4.4 |
|
|
Dividends |
|
|
– |
|
–20.4 |
|
– |
|
– |
|
– |
|
–20.4 |
|
– |
|
–20.4 |
|
|
Equity as of December 31, 2024 |
|
|
0.4 |
|
498.9 |
|
–14.5 |
|
–6.0 |
|
–42.4 |
|
436.4 |
|
10.3 |
|
446.7 |
|